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Secondary lymphoid organs (SLOs) promote primary
immune responses by recruiting naive lymphocytes
and activated APCs. However, their role in the persis-
tence or responsiveness of memory lymphocytes is
unclear. We tested whether memory cells were main-
tained and could respond to challenge in the absence
of SLOs. We found that influenza-specific CD8 cells
in the lung acquired a memory phenotype, underwent
homeostatic proliferation, recirculated through non-
lymphoid tissues, and responded to and cleared a
challenge infection in the complete absence of SLOs.
Similarly, influenza-specific virus-neutralizing anti-
body was generated and maintained in the absence
of SLOs. Inducible bronchus-associated lymphoid
tissue (iBALT) was also formed in the lungs of previ-
ously infected mice and may provide a niche for the
maintenance of memory cells at the local level. These
data show that SLOs are dispensable for the mainte-
nance of immunologic memory and directly demon-
strate the utility of local tissues, such as iBALT, in sec-
ondary immune responses.
Introduction
Unlike naive cells, which primarily home to secondary
lymphoid organs (SLOs), such as lymph nodes and
spleen, antigen-specific memory and effector cells are
found in both lymphoid and nonlymphoid tissues (Maso-
pust et al., 2001; Reinhardt et al., 2001). The altered
homing properties of memory cells can be explained by
differences in the expression of adhesion molecules and
chemokine receptors on naive and memory cells (Camp-
bell et al., 2003). Moreover, even memory T cells are
often divided into central memory cells, which retain
CD62L and CCR7 expression as well as the ability to
recirculate through encapsulated SLOs, and effector
memory cells, which lack CD62L and CCR7 and are
found throughout the body in nonlymphoid organs (Sal-
lusto et al., 1999). In addition to differences in homing
properties, central memory cells are proposed to lack
*Correspondence: trandall@trudeauinstitute.orgimmediate effector function (Harris et al., 2002; Maso-
pust et al., 2001; Reinhardt et al., 2001; Sallusto et al.,
1999), but are poised to rapidly expand in SLOs and to
differentiate into a second round of effector T cells. In
contrast, effector memory cells can rapidly respond to
antigen stimulation with immediate effector functions
such as cytotoxic activity or cytokine production (Harris
et al., 2002; Masopust et al., 2001; Reinhardt et al., 2001).
Although the functional differences between central and
effector memory T cells are not as clear cut as originally
proposed (Ely et al., 2003b; Wherry et al., 2003), subsets
of memory T cells with different homing properties
clearly exist (Sallusto et al., 1999). Thus, if the ability of
some memory cells to home to lymphoid organs is func-
tionally important, then one would expect that the envi-
ronment of SLOs must be required for some activity(s) of
memory cells.
Antigen-specific memory and effector cells located
at sites of previous antigen encounter in nonlymphoid
organs, such as the lung, are also proposed to comprise
effector lymphoid tissue or ELT (van Panhuys et al.,
2005). According to proponents of this model, the ELT
that develops after influenza infection includes memory
and effector T cells distributed in the lung airways, in the
lung parenchyma, and even in the inducible bronchus-
associated lymphoid tissue (iBALT). These local T cells
are poised to exert their effector function upon encoun-
ter with antigen and to rapidly provide local immunity at
the probable site of pathogen re-encounter, even before
antigen-driven expansion of memory cells (Hogan et al.,
2001a, 2001b). In fact, these investigators argue that
the formation of stable ELT is an essential component
of protective immunity and that we should strive to
develop vaccines that mimic this process (van Panhuys
et al., 2005).
The idea that memory T cells reside in ELT also fits
nicely into a multistep model that has been proposed
to explain recall responses to respiratory viruses (Wood-
land and Randall, 2004). In this model, memory T cells
already present in the lung airways are the first cells to
encounter antigen upon challenge (Hogan et al., 2001a,
2001b). Although these cells do not proliferate in the air-
ways or exhibit cytotoxic activity in response to antigen,
they rapidly produce cytokines that help to limit viral
replication (Ely et al., 2003a; Hogan et al., 2002). In the
second step, large numbers of memory cells are rapidly
recruited to the airways in the absence of any cell divi-
sion (Ely et al., 2003a). These cells also produce cyto-
kines and exhibit cytotoxic activity. In the third step,
memory CD8 cells in SLOs proliferate and rapidly ex-
pand in response to antigen (Woodland and Randall,
2004). These cells are subsequently recruited to the lung
airways with a full range of effector activities and ulti-
mately contribute to viral clearance. In this model, cells
in ELT contribute to the early phase of recall responses,
while cells in SLOs contribute to the late phase of the re-
call response. Despite the elegance of this model, how-
ever, it remains unclear whether memory T cells in ELT
are replenished by those in SLOs, whether memory cells
in ELT recirculate through other tissues, and whether
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infection without input from memory T cells that reside
in SLOs.
We have begun to answer these questions by testing
whether immunologic memory can be maintained and
can respond to challenge in the absence of SLOs. We
found that influenza-specific CD8 cells acquired a mem-
ory phenotype, underwent homeostatic proliferation, re-
circulated through nonlymphoid tissues, and responded
to and cleared a challenge infection in the complete
absence of SLOs. Similarly, influenza-specific virus-
neutralizing antibody was generated and maintained in
the absence of SLOs. We also showed that iBALT was
formed in the lungs of previously infected mice and that
memory cells proliferated in iBALT upon challenge in-
fection. These data show that SLOs are dispensable for
the maintenance of immunologic memory and directly
demonstrate the utility of local tissues, such as iBALT,
in secondary immune responses.
Results
Influenza-Specific Memory CD8 T Cells Are
Maintained in Mice Lacking SLOs
In order to test the ability of memory T cells to be main-
tained independently of SLOs, we first generated mice
lacking spleen, lymph nodes, and Peyer’s patches. To
do this, we reconstituted splenectomized, lethally irradi-
ated Lta2/2 mice with normal bone marrow (BM). Lta2/2
mice do not develop lymph nodes or Peyer’s patches
(de Togni et al., 1994), even after restoration of Lta+/+
cells (Rennert et al., 1996). Thus, splenectomized, re-
constituted Lta2/2 mice entirely lack spleen, lymph
nodes, and Peyer’s patches and are referred to as SLP
mice. As controls, we reconstituted lethally irradiated
C57BL/6 mice with C57BL/6 BM to generate wild-type
(WT) mice, and we reconstituted Lta2/2 mice with
Lta2/2 BM to generate LTa knockout (LTKO) mice.
In our initial experiments, we infected WT and SLP
mice with influenza A/PR8/34 (PR8) and enumerated the
CD8 T cells in the lungs responding to influenza nucleo-
protein366-374 (NP) (Figures 1A and 1B). The frequency of
NP-specific CD8 T cells peaked around day 10 and grad-
ually declined over the next 60 days. The majority of
these cells expressed low amounts of CD62L through-
out the kinetic study (Figure 1A), consistent with the
phenotype of effector or effector memory T cells. In con-
trast, relatively few NP-specific CD8 T cells expressed
the memory cell marker CD127 (IL-7Ra) at the peak of
the response, while nearly half of the NP-specific CD8
cells expressed CD127 at later times (Figure 1B). Impor-
tantly, the total numbers of NP-specific CD8 cells in
the lungs of WT and SLP were nearly identical at all
times (Figure 1C). Similarly, the numbers of NP-specific,
CD127+ memory CD8 cells in the lungs of WT and SLP
mice were also nearly identical (Figure 1D). Finally,
although the percentage of NP-specific cells that
expressed CD127 was slightly higher in the lungs of SLP
mice than in WT mice (Figure 1E), this difference was not
significant at any time (p = 0.10 on day 60). Thus, the lack
of SLOs does not impair the generation or short-term
maintenance of memory CD8 cells in the lung.
Since memory CD8 cells are maintained by constant
low-level proliferation (Hogan et al., 2002), we nextexamined whether memory CD8 cells in WT and SLP
mice were proliferating at the same rate. To test this,
we infected WT and SLP mice with PR8, waited 4 weeks
for memory to be established, and then administered
BrdU in the drinking water for a duration of 1, 2, or 3
weeks. We subsequently harvested cells from the lungs
of treated mice and determined the amount of BrdU
incorporation in NP-specific CD8 cells by flow cytometry
(Figure 1F). In addition, the frequency of NP-specific
CD8 cells that incorporated BrdU steadily increased
over the 3-week labeling period in both the lung and in
the BM (Figure 1G). Since the rate of BrdU incorporation
was identical in WT and SLP mice, we concluded that
the homeostatic proliferation of memory CD8 T cells
occurs independently of SLOs.
To assess the role of peripheral lymphoid organs in
generating and maintaining functional memory CD8 cells
that could respond to and clear a challenge infection,
groups of chimeric mice were initially infected with a
sublethal dose of PR8 and either rested for 138 days (Fig-
ures 2A and 2B, top row shows resting memory) or chal-
lenged with influenza A/HK-x31 (X31) on day 132 and an-
alyzed on day 138 (Figures 2A and 2B, middle row shows
heterotypic challenge). Since X31 expresses different
serotypes of the surface hemagglutinin and neuramini-
dase proteins, it is not neutralized by antibodies against
PR8 (Johansson et al., 1989; Johansson and Kilbourne,
1990). However, X31 and PR8 share internal proteins,
including NP. Thus, memory T cells will respond to epi-
topes in those proteins that are common to both viruses.
As a control, a third group of mice was mock infected on
day 0, challenged with X31 on day 132, and analyzed on
day 138 (Figures 2A and 2B, bottom row shows primary
infection). As shown in Figures 2A and 2B (top row),
NP-specific CD8 memory cells were found at similar fre-
quencies in the lungs of all groups of resting memory
mice, consistent with the data in Figure 1. Most of these
memory CD8 T cells expressed low amounts of CD62L.
Moreover, memory CD8 T cells responding to challenge
infection with X31 accumulated to high numbers in the
lungs of WT and SLP mice and lower numbers in LTKO
mice by day 6 after heterotypic challenge (Figures 2A
and 2B, middle row). Furthermore, it was clear that the
NP-specific CD8 cells responding to heterotypic chal-
lenge were derived from memory cells, since their fre-
quency was much higher than in mice responding to
X31 for the first time (Figures 2A and 2B, bottom row).
Consistent with the rapid accumulation of influenza-
specific CD8 T cells in the lungs of memory chimeric
mice, but not in naive chimeric mice responding to pri-
mary infection with X31, the viral titers in the lungs of
all groups of memory mice were reduced relative to the
viral titers in the lungs of naive chimeras (Figure 2C).
However, WT and SLP mice cleared virus more effi-
ciently than did LTKO mice. Although some of the chal-
lenged mice had undetectable titers of virus in their
lungs at day 6 post-challenge, it was clear that all mice
in these groups were infected: each of the mice showed
substantial morbidity and weight loss over the 6 day pe-
riod (Figure 2D). Together, these results demonstrate
that memory CD8 T cells can be maintained indepen-
dently of SLOs.
Although it was clear that memory cells were main-
tained and could respond in mice that lacked SLOs, it
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645Figure 1. The Generation and Maintenance of Memory CD8 T Cells Occurs Independently of SLOs
Recipient C57BL/6 or Lta2/2mice were irradiated and reconstituted with BM from C57BL/6 or Lta2/2mice. C57BL/6 mice receiving C57BL/6 BM
are referred to as WT mice. Splenectomized Lta2/2mice receiving C57BL/6 BM are referred to as SLP mice. Lta2/2mice receiving Lta2/2BM are
referred to as LTKO mice.
(A–E) Chimeric mice were infected with 100 EIU of PR8 on day 0, and cells from the lungs of WT and SLP mice were analyzed by flow cytometry at
the indicated times.
(A) Expression of CD62L on NP-specific CD8 T cells. The plots shown are gated on CD8 T cells.
(B) Expression of CD127 on NP-specific CD8 T cells. The plots shown are gated on CD8 T cells.
(C) The total number of NP-specific CD8 T cells in the lungs was calculated as defined by the boxed areas in (A).
(D) The total number of NP-specific memory T cells was calculated as defined by the boxed areas in (B).
(E) The percentage of NP-specific CD8 T cells in the lung that expressed the memory marker, CD127, was calculated based on the boxed areas in
(B). The data in (C)–(E) represent the mean and standard deviation from 3–4 mice per group at each time point. The data shown are representative
of two independent experiments.
(F and G) Groups of chimeric mice were infected with 100 EIU of PR8, provided BrdU in the drinking water starting on week 4, and analyzed 1, 2,
and 3 weeks after the start of BrdU treatment.
(F) Representative BrdU incorporation in NP-specific CD8 T cells 3 weeks after the provision of BrdU. The plots shown are gated on CD8 T cells.
(G) Rate of BrdU incorporation into NP-specific memory CD8 T cells in lungs and BM of WT and SLP mice. The data represent the mean and
standard deviation from three mice per group at each time point. The data shown are representative of three independent experiments.was not clear where this response occurred. It was pos-
sible that memory T cells proliferated locally, perhaps in
the iBALT areas of the lung, or that memory T cells pro-
liferated at systemic sites, like the BM, and subse-
quently migrated to the lung. To distinguish these possi-
bilities, we infected mice with PR8, allowed memory
cells to develop for 11 weeks, and challenged the mem-
ory mice with X31. Five days later, we treated challenged
mice for 12 hr with FTY720 to sequester cells in tissues
and prevent trafficking between organs (Cyster, 2005).
We then pulsed the mice for 2 hr with BrdU and looked
for antigen-specific T cells that had incorporated
BrdU. We found that treatment with FTY720 did not sub-
stantially change the number of total cells (Figure 3A) or
CD8 cells (Figure 3B) in the BM or lung. However,
FTY720 treatment substantially reduced the numbers of
cells in the blood, including CD8 cells (Figures 3A and
3B). Thus, FTY720 sequesters cells in tissues, even when
SLOs are absent.We next examined whether NP-specific CD8 cells in
the lung had incorporated BrdU during the 2 hr pulse.
As shown in Figure 3C, we found CD8+BrdU+ cells (red
arrows pointing left) as well as tetramer+CD8+BrdU+
cells (violet arrows pointing right) in all groups of mice,
regardless of FTY720 treatment. Many BrdU+ cells
were found in clusters consistent with the placement
of iBALT around major blood vessels and airways
(Figure 3C). However, BrdU+ cells were also found in
alveolar areas (see Figure S1 in the Supplemental Data
available online). Representative CD8+BrdU+ cells (red)
and tetramer+CD8+BrdU+ cells (violet) from each group
are enlarged in Figure 3D. These data demonstrate
that NP-specific memory CD8 T cells proliferate directly
in the lungs of challenged mice.
We also enumerated the frequency of BrdU incorpora-
tion in NP-specific CD8 cells that were responding in the
lung and BM. As shown in Figure 3E, NP-specific cells
proliferated at higher frequencies in the lung than in
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Challenge
(A and B) Groups of chimeric mice were infected with 100 EIU PR8 (top and middle) or mock infected (bottom) on day 0. The chimeric mice were
then challenged with 5000 EIU X31 on day 132 (middle and bottom) or left unchallenged (top). Cells from all groups were analyzed 6 days later on
day 138.
(A) Dot plots show representative expression of CD62L and H-2DbNP366-374 tetramer binding on CD8
+ lymphocytes isolated from the lung on day
138 (day 6 postchallenge).
(B) The mean percentage of CD8 cells that are antigen specific (tetramer binding) in each group of chimeras is shown.
(C) The viral titers in the lungs of WT (square), SLP (diamond), and LTKO (circle) mice were determined on day 138 (day 6 postchallenge). Dashed
line indicates limit of detection.
(D) The mean change in weight of each group from day 132 to day 138 is shown. The data represent the mean and standard deviation from four
mice per group. This data shown are representative of two independent experiments.the BM of both WT and SLP mice. In addition, treatment
with FTY720 had no discernable affect on the frequen-
cies of BrdU incorporation in either the lung or the BM
of any group. Given these data, we conclude that mem-
ory cells responding in the absence of secondary lym-
phoid organs proliferate primarily in the lung and to a
lesser extent in the BM. Furthermore, we conclude that
the responding memory T cell population in the lung is
not dependent on cells that proliferate in the BM and
then home to the lung.
Neither Effector nor Central Memory Cells Require
SLOs to Respond to Antigenic Challenge
Most of the memory cells maintained in the lungs of
either WT or SLP mice expressed low amounts of CD62L,
consistent with the phenotype of effector, rather than
central memory cells (Figure 2A). Although other studies
have clearly shown that both effector and central mem-
ory cells have the ability to respond to challenge infec-
tions, it was not clear whether either population required
SLOs for activation and expansion. To test whether
central or effector memory CD8 cells required SLOs
to respond to influenza, we infected normal C57BL/
6.CD45.1 mice with PR8, allowed memory cells to de-
velop for 40 days, and sorted polyclonal populations of
effector memory cells (CD8+CD44hiCD62Llo) or central
memory cells (CD8+CD44hiCD62Lhi) from the spleen.
Equivalent total numbers of these cell populations were
injected into WT and SLP chimeric mice (both CD45.2),
and the recipient mice were infected with PR8 1 day
later. We found that NP-specific, donor-derived CD8
cells from both effector and central memory populationsresponded to challenge in the lung tissue (Figures 4A and
4B) and BAL (Figures 4C and 4D) of both WT and SLP
mice. Effector memory cells expanded slightly better in
SLP than in WT mice and central memory cells expanded
slightly better in WT than in SLP mice. However, the
differences were not statistically significant. Similar re-
sults were observed with PA-specific CD8 T cells (not
shown). Thus, despite the ability of CD62L to bind PNAd-
expressing HEVs and promote homing to peripheral
lymph nodes, SLOs are not required for the expansion
of either central or effector memory CD8 cells.
The fact that both central and effector memory popu-
lations respond similarly in WT and SLP mice suggested
that these cell populations may be more promiscuous in
their migratory habits than previously thought (Harris
et al., 2002; Sallusto et al., 1999). Although it is clear that
memory CD8 cells are constantly recirculating through
most tissues in the body (Klonowski et al., 2004), it is
not clear whether the memory CD8 cells in peripheral
organs are seeded by those recirculating through SLOs,
or whether the memory cells from peripheral tissues also
recirculate. To test whether memory cells in peripheral
tissues are part of the recirculating pool, we infected
WT and SLP mice with PR8, waited 30 days for memory
cells to become established, and then performed para-
biosis with CD45.1 partners. The parabiotic pairs were
separated at 10 days after parabiosis, and donor-
derived NP-specific memory cells were enumerated by
flow cytometry in each partner (Figures 5A and 5B). As
shown by the circled populations in Figures 5A and
5B, CD8 cells from WT and SLP mice rapidly colonized
the lungs of their CD45.1 partners and vice versa. As
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cells responding to NP and PA epitopes were derived
only from the CD45.2 partners (WT and SLP mice) and
not from the naive CD45.1 partners (Figures 5A and
5B, boxed areas). As shown in Figure 5C, CD45.2+ NP-
specific CD8 cells as well as total CD45.2+ CD8 T cells
were equally distributed in the lungs and spleens of
WT/CD45.1 pairs. In addition, there were slightly (but
not significantly) more CD45.2+ NP-specific and total
CD45.2+ CD8 T cells in SLP mice than in their CD45.1
partners. Moreover, CD45.2+ NP-specific and total CD8
T cells from SLP mice repopulated the spleens of their
CD45.1 partners, even though SLP mice lack spleens
and lymph nodes of their own (Figure 5D). These data
demonstrate that memory CD8 T cells are rapidly recir-
culating in and out of peripheral nonlymphoid organs,
even when SLOs are not present.
We also surveyed a more extensive panel of tissues
on day 15 after parabiosis. As shown in Figure 5E,
CD45.2+ NP-specific CD8 T cells were found at similar
frequencies in the lungs, livers, popliteal lymph nodes,
and spleens of WT and their CD45.1 partner mice. In
addition, CD45.2+ NP-specific CD8 T cells were found
at similar frequencies in the lungs and livers of SLP
and their CD45.1 partner mice (Figure 5F). Furthermore,
the frequency of CD45.2+ NP-specific CD8 T cells in the
popliteal lymph nodes and spleens of CD45.1 mice that
were partnered to SLP mice were very similar to the
frequency of those found in the popliteal lymph nodes
and spleens of CD45.1 mice partnered to WT mice, even
though SLP mice do not have spleens or lymph nodes.
These data demonstrate that memory CD8 T cells can re-
circulate from peripheral nonlymphoid organs to SLOs.
Influenza-Specific Antibodies Are Produced and
Maintained in Mice Lacking SLOs and Can Neutralize
Virus in Response to Homotypic Challenge
The long-term production of high-affinity neutralizing
antibody is another major component of resistance to
secondary influenza infection (Gerhard, 2001; Lee
et al., 2005). To test whether long-lived antibody was
produced in the absence of lymph nodes and spleen,
we infected chimeric mice with 100 EIU of PR8 and mea-
sured influenza-specific IgM and IgG titers at days 0, 28,
and 120 after infection. As controls, a second group of
chimeric mice were not infected with PR8. As shown in
Figure 6A, robust antibody responses were generated
in all groups of PR8-infected chimeras as evidenced
by the titers of IgM and IgG at day 28 relative to those
at day 0. Although PR8-infected WT mice clearly made
higher titers of IgG relative to SLP and LTKO mice, all
groups were well above background. In contrast, while
influenza-specific IgM titers were relatively low in PR8-
infected WT mice on day 28, IgM titers were somewhat
higher in SLP mice and substantially higher in LTKO
mice (Figure 6A). These trends were also observed 120
days after initial infection, although titers were lower
overall at this time (Figure 6A). These results demon-
strate that the generation and long-term production of
isotype-switched influenza-specific antibody does not
require peripheral lymphoid organs.
To determine whether the antibody observed in the
serum of chimeric mice was able to neutralize a chal-
lenge infection with the same virus, we challenged bothmemory and naive chimeric mice with 1000 EIU of PR8
(near the LD50) on day 132 after the initial infection. We
then assayed viral titers in the lungs 6 days after chal-
lenge infection. As shown in Figure 6B, all groups of
mice that were infected with PR8 for the first time had
consistently high viral titers in their lungs. In contrast, all
PR8-immune mice that were challenged with PR8 had
undetectable viral titers, regardless of the group (Fig-
ure 6B). Consistent with the idea that virus had been
neutralized by antibody, the PR8-immune mice chal-
lenged with PR8 showed no signs of infection and did
not lose any weight (Figure 6C). In contrast, all groups
of the naive mice challenged with PR8 rapidly showed
signs of infection and consistently lost nearly 20% of
their initial body weight in the 6 days after challenge in-
fection (Figure 6C). In addition, the memory CD8 T cells
present in the lungs of challenged chimeric mice did not
expand after homotypic challenge (Figures 6D and 6E),
suggesting that virus was completely neutralized by
antibody and a productive infection did not take place.
Together, these data demonstrate that neither LTa nor
peripheral lymphoid organs are necessary for the
production and maintenance of high-affinity, isotype-
switched antibodies that are capable of neutralizing
virus.
Inducible Bronchus-Associated Lymphoid Tissue
Is Maintained for Extended Periods
after Influenza Infection
ELT is defined to include cells in the lung airways, the
lung tissue, and even in local, inducible lymphoid tis-
sues, such as inducible bronchus-associated lymphoid
tissue (iBALT) (van Panhuys et al., 2005). Since we pre-
viously showed that iBALT is rapidly generated in the
lungs of influenza-infected mice (Moyron-Quiroz et al.,
2004), we next wanted to test how long iBALT was main-
tained in the lungs of chimeric mice. Therefore, we in-
fected groups of chimeric mice with PR8, and sections
of lung tissue were analyzed for iBALT 30, 50, and
90 days after infection. We found areas of iBALT in the
lungs of both WT and SLP mice at all times after infection
(Figures 7A–7F). These areas of iBALT contained sepa-
rated B and T cell areas, and the B cell follicles were or-
ganized around CD21-expressing follicular dendritic
cells. Areas of iBALT were often embedded in larger
inflammatory lesions, particularly at early times after in-
fection (Figures 7A and 7B). In contrast, iBALT was not
found in the lungs of LTKO mice, despite the presence
of large inflammatory infiltrates that contained both B
and T cells (Figure 7G). In addition, B and T cells were in-
termixed, and CD21-expressing FDCs were never ob-
served in the lungs of LTKO mice, similar to that in the
spleens of Lta2/2 mice. We also quantified the number
and size of iBALT areas in WT and SLP mice. Interest-
ingly, although the average size of individual iBALT areas
remained fairly constant in WT mice out to 90 days, the
number of iBALT areas observed was reduced at this
time, making them more difficult to find (Figure 7H).
In contrast, although the larger iBALT areas in SLP
mice appear to remain for extended periods, numerous
smaller areas also become evident at later times after
infection. When combined, these changes lead to a
modest reduction of total iBALT area in WT mice and
a substantial increase in the total iBALT area over time
Immunity
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WT and SLP mice were infected with PR8, and memory T cells were allowed to develop for 11 weeks. Mice were then challenged with X31 and
treated with FTY720 5 days later. After 12 hr, they were pulsed with BrdU for 2 hr and analyzed.
(A) Total live cells were enumerated in the BM, lung, and blood of treated mice.
(B) CD8 T cells were enumerated in the BM, lung, and blood of treated mice by flow cytometry.
(C) Live thick sections were probed with antibodies to BrdU (green) and CD8 (red) as well as tetramers (blue) to identify NP-specific CD8 T cells
that had divided during the BrdU pulse. Red arrows pointing to the left indicate CD8+ cells, while violet arrows pointing to the right indicate
CD8+tetramer+ cells. Overexposed autofluorescence is pseudocolored in white to identify structural elements in the lung.
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B6.CD45.1 mice were infected with 100 EIU of PR8 and allowed to develop memory CD8 cells for 30 days, when CD8 T cells were positively
selected from spleen and lymph nodes via magnetic beads. The positively selected CD8 cells were sorted into CD8+CD44hiCD62Llo effector
memory cells or CD8+CD44hiCD62Lhi central memory T cells. 73 104 total cells from these populations (not normalized for the number of influ-
enza-specific cells) were then injected into WT and SLP mice (both CD45.2), which were challenged with 100 EIU PR8 the next day.
(A) CD8 T cells from the lung tissue were analyzed by flow cytometry for NP tetramer binding and for the expression of the CD45.1 donor marker
on day 10 after challenge. The plots shown are gated on CD8 T cells.
(B) The number of donor-derived (CD45.1+) NP-specific CD8 T cells was enumerated in the lung tissue.
(C) CD8 T cells from the BAL were analyzed by flow cytometry for NP tetramer binding and for the expression of the CD45.1 donor marker on day
10 after challenge. The plots shown are gated on CD8 T cells.
(D) The number of donor-derived (CD45.1+) NP-specific CD8 T cells was enumerated in the BAL. The data in (B) and (D) represent the mean and
standard deviation from five mice per group. Statistical differences were determined by unpaired t test. The data shown are representative of
three independent experiments.in SLP mice. (Figure 7I). Thus, iBALT persists for ex-
tended periods after infection and likely plays a role in
the maintenance and reactivation of memory cells,
even in normal mice that have SLOs.
Discussion
Despite the common perception that SLOs are neces-
sary for the activation and proliferation of lymphocytes,
our data show that naive cells can be primed and differ-
entiate into functional memory cells independently of
SLOs. The maintenance of memory cells in peripheral
nonlymphoid tissues by homeostatic proliferation also
occurs normally in the absence of SLOs. Furthermore,
memory cells in peripheral tissues can respond to and
clear a challenge infection locally, without first expand-
ing in SLOs. Together, these data alter our perceptions
of how populations of memory cells in peripheral, non-
lymphoid tissues contribute to a functional state of
immunologic memory.
Although our data clearly demonstrate that homeo-
static proliferation of memory CD8 T cells occurs inde-
pendently of SLOs, it does not indicate where this prolif-
eration does take place. One possibility is that memory
CD8 cells proliferate in situ in nonlymphoid organs,
such as the lung parenchyma or even in the iBALT areas
of the lung (Moyron-Quiroz et al., 2004). This wouldmake sense if persistent antigen is required for the
long-term maintenance of memory or effector T cells in
ELT. In fact, some antigen is retained after influenza in-
fection is resolved and is presented to both CD4 cells
(Jelley-Gibbs et al., 2005) and CD8 cells (Zammit et al.,
2006). However, other data show that memory CD8
T cells can be maintained in the complete absence of
MHC class I molecules (Murali-Krishna et al., 1999),
demonstrating that antigen is not essential for their
maintenance. An alternative site for homeostatic prolif-
eration is in the BM. This second possibility makes
sense, since the rate of homeostatic proliferation in the
BM is higher than that in other sites (Figure 2). In addi-
tion, the maintenance of memory CD8 cells is dependent
on IL-15 (Becker et al., 2002; Zhang et al., 1998) and IL-7.
IL-15 is produced by activated macrophages (Jonuleit
et al., 1997) and dendritic cells (Doherty et al., 1996),
which are plentiful in the lung, BM, and other peripheral
sites, while IL-7 is produced by stromal cell types
(Gimble et al., 1989), such as those in the BM. Thus,
it is not altogether surprising that CD8 memory T cells
have the ability to survive and proliferate in peripheral
tissues, including BM and iBALT, without input from
SLOs.
Although we cannot determine with certainty whether
the homeostatic proliferation of memory T cells occurs
locally in areas like iBALT or at other sites, like the BM,(D) Selected cells from the images in (C) were enlarged to more clearly show the difference between CD8+tetramer2 cells (red) and CD8+tetramer+
cells (violet).
(E) The frequency of BrdU incorporation in NP-specific CD8 cells from the BM and lung was determined by flow cytometry. Images are repre-
sentative of multiple sections from 2–3 mice and flow cytometric data was obtained from 4–5 mice per group. The data shown are representative
of two independent experiments.
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WT and SLP chimeric mice were infected with 300 EIU of X31 and allowed to develop memory CD8 T cells for 30 days. The chimeric mice (both
CD45.2) were then parabiotically joined with naive age-matched CD45.1 partners for 10–15 days.
(A and B) Parabiotic partners were separated on day 10, and cells from the lungs of each partner were analyzed for NP-specific CD8 T cells of
CD45.1 and CD45.2 genotypes. The top row of plots is gated on lymphocytes and the bottom row of plots is gated on CD8 T cells.
(C and D) Donor-derived (CD45.2+) NP-specific and total CD8 T cells were enumerated in the lungs and spleens of WT/partner and SLP/partner
pairs of mice on day 10 after parabiosis. The data in (C) and (D) represent the mean and standard deviation from four WT and four SLP parabiotic
pairs. Statistical differences were determined by paired t test.
(E and F) Donor-derived, NP-specific CD8 T cells were analyzed in the lungs, livers, pLNs, and spleens of WT/partner and SLP/partner pairs of
mice on day 15 after parabiosis. The plots shown are gated on CD8+CD45.2+ cells. Three WT and three SLP parabiotic pairs were used for this
analysis and the cells from each tissue/partner were pooled.our data clearly demonstrate that memory T cells can
respond to challenge in situ at sites of ELT, such as
iBALT. In fact, memory cells proliferated more rapidly
after challenge in the lung than in the BM, suggesting
that local activation of influenza-specific cells is more
efficient than systemic activation. Furthermore, treat-
ment of mice with the drug FTY720, which sequesters
cells in tissues and impairs recirculation, did not alterthe rate of proliferation in either the lung or the BM, dem-
onstrating that the BrdU+ cells did not proliferate else-
where and subsequently migrate to the lung. These
data are consistent with a report that adoptively trans-
ferred memory T cells (generated in WT hosts) do not
require lymphoid tissues for expansion or for effector
function (Chalasani et al., 2002). However, one interest-
ing and unresolved question is whether memory cells
Maintenance of Memory outside of Lymphoid Tissues
651Figure 6. Influenza-Specific, Virus-Neutralizing Antibody Is Generated and Maintained Independently of SLOs
Groups of chimeric mice were either infected with 100 EIU of PR8 or mock infected on day 0. Mice were bled for the analysis of serum antibodies
at days 0, 28, and 120 after primary infection. Mice were then challenged on day 132 with 1000 EIU of PR8 and analyzed on day 138 (day 6
postchallenge).
(A) The titers of influenza-specific IgM and IgG in the serum of WT (square), SLP (diamond), and LTKO (circle) mice were determined by influenza-
specific ELISA.
(B) Viral titers in the lungs of WT (square), SLP (diamond), and LTKO (circle) mice were determined on day 138 (day 6 postchallenge). Dashed line
indicates limit of detection.
(C) The mean change and standard deviation in weight of each group from day 132 to day 138 is shown.
(D) Dot plots show representative expression of CD62L and H-2DbNP366-374 tetramer binding on CD8
+ lymphocytes isolated from the lungs of
chimeric mice at day 138 (day 6 postchallenge).
(E) The mean percentage and standard deviation of CD8 cells that are antigen-specific (tetramer binding) in each group of chimeras is shown.
The data are representative of two independent experiments.respond to influenza more rapidly or provide more effi-
cient protection in normal mice that also have iBALT.
Despite the fact that iBALT clearly supports the local
reactivation of memory cells, it is probably not required
for local memory responses, as indicated by the fact that
we also observed memory cells proliferating in the non-
iBALT areas of the lung. Moreover, some memory cells
clearly proliferated in the BM. Since the BM is a lymphoid
organ that exists prior to infection, it is philosophically
difficult to argue that it is part of the ELT. Furthermore,
given the dynamic recirculation patterns of memory
cells in and out of peripheral sites, like the lung, it seems
that the memory cells in ELT are not truly separate from
the rest of the memory cells in the body. On the other
hand, there may be some sites, such as the lung airways
or intestinal mucosa, which recruit specialized subsets
of memory cells with more restrictive recirculation pat-
terns (Klonowski et al., 2004). Thus, the original concept
of ELT may be applicable to only a few areas in the body.
Another interesting aspect of our studies is the ability
of transferred central and effector memory T cell popu-
lations to respond to influenza independently of SLOs.
Despite the differences in homing properties of central
and effector memory T cells, our data show that neither
subset requires SLOs to respond to influenza and accu-
mulate in the lungs of infected mice. Although we did not
transfer sufficient numbers of either type of cells to im-
pact viral clearance, the fact that they expanded simi-
larly in the presence or absence of SLOs demonstrates
that the environment of SLOs is not essential for theirresponse. Given the homing properties of effector mem-
ory cells, it is not surprising that they respond in the
absence of SLOs. However, it is not entirely clear where
central memory cells might proliferate in SLP mice. One
possibility is that central memory cells proliferate in
iBALT, since iBALT has HEVs that express ligands for
the homing receptors on central memory cells (Moyron-
Quiroz et al., 2004). However, it takes time for iBALT to
form, and since we looked at memory cell expansion
only 10 days after infection, we would expect to see
a substantial delay in the expansion of memory cells
in SLP mice. Alternatively, central memory cells may
home to and proliferate in the BM as suggested by
others (Cavanagh et al., 2005; Mazo et al., 2005). How-
ever, our data also show that the total population of
memory cells proliferates more efficiently in the lung
than in the BM when challenged with influenza. This
makes sense, because influenza replication is restricted
to the respiratory tract and antigen is probably present
at much higher concentrations in the lung than in the
BM. In either case, the ability of central memory cells
to respond to influenza is not dependent on SLOs.
Our data also show that the recirculation pattern of
effector memory cells may also be more promiscuous
than previously thought. From the data in Figure 5, it is
clear that memory T cells in WT and SLP mice have
the ability to recirculate extensively through both SLOs
and nonlymphoid organs. Given that the popliteal lymph
nodes and spleens of CD45.1 mice accumulated mem-
ory CD8 T cells from their WT and SLP partners to the
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(A–G) Groups of chimeric mice were infected with 100 EIU of PR8 on day 0 and lungs were harvested, embedded in OCT, and frozen on days 30
(A, B, and G), 50 (C and D), and 90 (E and F) after infection. Frozen sections were stained with Diff Kwik to visualize histopathology and with
antibodies to CD3, B220, CD21, and CD11c to visualize T cells, B cells follicular dendritic cells, and dendritic cells/macrophages, respectively.
Immunofluorescent sections were counterstained with DAPI (blue). Fluorescent images were obtained with a 103 objective and histology
images were obtained with a 2.53 objective. Images are representative of 2–4 mice per group in 3 independent experiments.
(H) The mean and standard deviation of the cross-sectional areas of individual iBALT areas were measured from seven lung midsections from
each group. The numbers in parentheses above each bar indicates the total number of iBALT areas that were measured in seven sections.
(I) The portion of the lung that contained iBALT was determined by totaling the iBALT areas and dividing by the total lung area in all seven
sections.same degree (Figures 5E and 5F), this suggests that
there is a substantial traffic of memory cells from periph-
eral nonlymphoid tissue to SLOs. This is consistent with
data showing that CCR7+ effector T cells in peripheral
tissues rapidly drain via the lymphatics to downstream
lymph nodes (Bromley et al., 2005; Debes et al., 2005).
Although we did not examine CCR7 expression on the
memory cells maintained in SLP mice, most memory
CD8 cells in the lungs of these mice expressed low
amounts of CD62L (Figure 1), consistent with the pheno-
type of effector memory cells. Regardless of what types
of memory cells are involved, it is now clear that the
traffic of memory cells occurs both to and from periph-
eral nonlymphoid organs.
We also found that isotype-switched antibody is gen-
erated and maintained for extended periods in mice thatlack SLOs. We previously demonstrated that germinal
centers could form directly at the site of infection in
iBALT (Moyron-Quiroz et al., 2004), and our current
data suggest that these germinal centers produced
long-lived antibody-secreting plasma cells. Since long-
lived plasma cells are thought to reside in the BM
(Manz et al., 1997), it is not too surprising that SLOs
are not required for their maintenance. However, long-
lived antibody-secreting cells are also thought to be
maintained in the lung after influenza infection (Jones
and Ada, 1986, 1987). Thus, we should also think of
long-lived plasma cells as part of ELT. They clearly ex-
hibit immediate effector function—the secretion of anti-
gen-specific antibodies, which should be most useful at
local sites of pathogen entry, where they act to neutral-
ize incoming pathogens. Although it is not clear whether
Maintenance of Memory outside of Lymphoid Tissues
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also be a component of ELT. Since memory B cells have
the ability to rapidly differentiate into antibody-secreting
cells in response to inflammatory signals without BCR
signaling or cognate T cell help (Traggiai et al., 2003),
they also exhibit immediate effector function. Thus,
both long-lived plasma cells and memory B cells should
be considered components of local ELT.
In summary, this study demonstrates that immuno-
logic memory can be generated and maintained inde-
pendently of SLOs. Influenza-specific CD8 cells in the
lung can acquire a memory phenotype, undergo homeo-
static proliferation, recirculate through nonlymphoid
tissues, and respond to and clear a challenge infection
in the complete absence of SLOs. Similarly, influenza-
specific, virus-neutralizing antibodies are generated
and maintained in the absence of SLOs. These data
directly demonstrate the autonomous nature of memory
cells located outside SLOs and the utility of local ELT in
secondary immune responses.
Experimental Procedures
Mice and Generation of BM Chimeras
C57BL/6 mice, B6.SJL-PtrpcaPep3b/BoyJ (CD45.1 mice), and
C57BL/6.129Ltatm1Dch (Lta2/2 mice) were obtained from Jackson
Laboratory and were bred and maintained in the Animal Breeding
Facility at the Trudeau Institute. Chimeric mice were generated by
lethal irradiation (1000 rads from a 137Cs source at 93 rad/min in
two doses) and reconstitution with 13 107 BM cells. All procedures
with animals were approved by the Trudeau Institute IACUC or the
University of Connecticut IACUC and were conducted according
to the principles outlined by the National Research Council.
Parabiosis
Parabiosis surgery was performed as described (Klonowski et al.,
2004). Female WT or SLP chimeric mice were infected with influenza
and parabiosed with age- and sex-matched naive CD45.1 mice. The
blood supplies of the two parabiotic partners were connected by
making an incision in the skin on the opposing flanks of the donor
and recipient animals. Surgical sutures were used to bring the
body walls of the partners into direct contact. The outer skin was
then stabilized with surgical staples. Joined animals were main-
tained for 10 or 15 days after surgery, when the animals were sacri-
ficed, separated, and analyzed.
Influenza Infection and Quantification
In primary infections, mice were infected intranasally with 100 egg
infectious units (EIU) of influenza A/PR8/34 (PR8) in 100 ml or with
300 EIU of A/HK-x31 (X31). Secondary infections were performed
with PR8 at 1000 EIU in 100 ml, or with X31 at 5000 EIU in 100 ml. Viral
titers were determined in embryonated chicken eggs as described
(Lund et al., 2002).
Flow Cytometry and Cell Sorting
Tissues were mechanically disrupted by passage through a wire
mesh, and live leukocytes were obtained by density gradient centri-
fugation with Lympholyte-Poly (Cedarlane). Fc receptors were
blocked with 10 mg/ml 2.4G2, followed by staining with antibodies
or MHC class I tetramers. The H-2Db class I tetramers containing
NP366-374 peptide or PA224-233 peptide were generated by the Tru-
deau Institute Molecular Biology Core Facility. For analysis of
BrdU incorporation, cells were first stained with antibodies to sur-
face markers as described above, fixed in 1% paraformaldehyde,
and permeablized with 0.05% Nonidet P40 in PBS. BrdU epitopes
were exposed by treating cells with 50 Kunitz U/ml of freshly pre-
pared DNase I (Sigma) in 4.2 mM MgCl2, 150 mM NaCl (pH 5.0). Cells
were subsequently washed in PBS and stained with anti-BrdU (BD
Biosciences). In cell-sorting experiments, CD8 cells were first
enriched with anti-CD8 magnetic microbeads and MACS columns(Miltenyi Biotec). Enriched CD8 cells were then purified by cell sort-
ing with a high-speed FACSVantage SE equipped with DiVa option.
Administration of FTY720 and BrdU
BrdU (Sigma) was administered daily in the drinking water at
0.8 mg/ml or injected intraperitoneally at 2 mg/mouse. FTY720
(Cayman Chemical) was intraperitoneally injected (4 mg/kg).
ELISAs
Influenza-specific ELISAs were performed by coating plates with
purified influenza proteins at 1 mg/ml. Influenza proteins were ob-
tained as described (Lee et al., 2005). Serum samples were diluted
in 3-fold serial dilutions in PBS with 10 mg/ml BSA and 0.1%
Tween-20 prior to incubation on coated plates. Bound Ig was
detected with horseradish peroxidase-conjugated goat-anti-mouse
IgM or goat anti-mouse IgG (Southern Biotechnology).
Histology and Immunofluorescence
For frozen sections, lungs were inflated with OCT (Sakura Finetek),
embedded in OCT, and frozen over liquid nitrogen. Frozen sections
(7 mm) were fixed in acetone, air dried, and either stained with Diff
Kwik (Fisher) or used for immunofluorescence. Biotinylated anti-
B220, anti-CD3, anti-CD11c, and anti-CD21/CD35 were purchased
from BD Biosciences. Biotinylated antibodies were detected with
strepavidin conjugated to either Alexa 488 or Alexa 594 (Molecular
Probes). All frozen sections were viewed with a Zeiss Axioplan 2 mi-
croscope. Images were recorded with a Zeiss AxioCam digital
camera. The area of iBALT in frozen sections was calculated with
the outline tool in Zeiss AxioVision 4.5 software.
For live thick sections, lungs were instilled intratracheally with 3%
low-melt agarose (Sea Plaque). The trachea was ligated and the lung
was removed and placed in cold PBS containing 2% FCS and 0.02%
NaN3. Thick 100 mm sections were cut on a Leica VT1000s vibrating
microtome and stained in 24-well plates. Sections were incubated
for 1 hr with Fc block and stained with APC-conjugated tetramer
and Alexa 594-conjugated anti-CD8. After washing, the APC-conju-
gated tetramer was amplified with rabbit anti-APC (Biomeda) fol-
lowed by Alexa 647-conjugated anti-rabbit IgG (Invitrogen). Stained
sections were fixed in absolute EtOH for 15 min, washed in PBS, and
incubated in 0.5 M HCL with 1% Triton X-100 for 30 min to denature
the DNA. Tissues were washed PBS with 1% Triton X-100 and
stained with Alexa 488-conjugated anti-BRDU overnight. Images
were captured with a Zeiss Axiovert 200 inverted microscope equip-
ped with an Apitome (optical grid and software) with a Plan-
Apochromat 203/0.75 NA objective. Green, blue, and red fluores-
cence was captured with appropriate filter sets, and wide-spectrum
autofluorescence was collected and pseudocolored in white to visu-
alize tissue structure. Images are optical sections collected in Zeiss
AxioVision 4.5 software and saved as TIFF files.
Supplemental Data
One Supplemental Figure can be found with this article online at
http://www.immunity.com/cgi/content/full/25/4/643/DC1/.
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